Ade Rifka Junita
Overview
Explore the profile of Ade Rifka Junita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Junita A, Hamid F, Budu B, Natzir R, Hala Y, Alam G, et al.
Heliyon
. 2023 Dec;
9(11):e22327.
PMID: 38058621
Purpose: To prove the effect of Miana (M), Quercetin (Q), and the combination as an anti-inflammatory agent and Cefixime (C) as an antibiotic in Balb/c mice infected with serovar Typhi...
2.
Fachri M, Hatta M, Lestari F, Akaputra R, Fatimah F, Wahab A, et al.
Ann Med Surg (Lond)
. 2023 Oct;
85(10):4799-4805.
PMID: 37811025
Background: Chronic obstructive pulmonary disease (COPD) is characterised by persistent and progressive airflow limitations. The study aimed to determine the relationship between eosinophil values in patients with stable and exacerbated...
3.
Dwiyanti R, Muthaher A, Achmad D, Arsyadi G, Nelwan B, Cangara M, et al.
Ann Med Surg (Lond)
. 2023 Jun;
85(6):2587-2591.
PMID: 37363504
Methods: Determination of NRAMP-1 protein levels using the enzyme link-immunosorbent assay technique in death, had comorbidities and severity of clinical symptoms of COVID-19 patients. Results: Of the 62 patients who...
4.
Taufik F, Natzir R, Patellongi I, Santoso A, Hatta M, Junita A, et al.
Ann Med Surg (Lond)
. 2022 Sep;
81:104388.
PMID: 36147103
For centuries, propolis has been used to treat various diseases in traditional medicine due to its biological and pharmacological activities. It remains popular because of its potentially beneficial role in...
5.
Fachri M, Hatta M, Tarigan S, Akaputra R, Dwiyanti R, Syukri A, et al.
Ann Med Surg (Lond)
. 2022 Jul;
79:104042.
PMID: 35784948
Background: Thrombotic complications of coronavirus disease 2019 (COVID-19) are a worrisome aspect of the disease due to their high incidence in critically ill patients and their poor clinical outcomes. The...
6.
Fachri M, Hatta M, Widowati E, Akaputra R, Dwiyanti R, Syukri A, et al.
Ann Med Surg (Lond)
. 2022 Apr;
77:103553.
PMID: 35382457
Background: Patients with comorbidities have an increased risk for severe coronavirus disease (COVID-19) symptoms, including abnormal inflammation. Chest X-rays and C-reactive protein (CRP) level are frequently used to evaluate the...
7.
Syukri A, Budu , Hatta M, Amir M, Rohman M, Mappangara I, et al.
Ann Med Surg (Lond)
. 2022 Mar;
76:103501.
PMID: 35340325
Background: Doxorubicin (DOX) is a commonly used treatment for cancer and the mechanism of DOX-induced cardiomyocyte damage in cardiovascular disease is not fully understood. High-mobility group box 1 (HMGB1), strong...
8.
Fachri M, Hatta M, Massi M, Santoso A, Wikanningtyas T, Dwiyanti R, et al.
Sci Rep
. 2021 Dec;
11(1):23162.
PMID: 34848800
Airway inflammation in patients with chronic obstructive pulmonary disease (COPD) is an amplified response of the normal immune system that occurs as a result of chronic irritation by toxic substances,...
9.
Simanjuntak T, Hatta M, Tahir A, Sirait R, Karo M, Tambaib T, et al.
J Glob Infect Dis
. 2019 Mar;
11(1):25-29.
PMID: 30814832
Background: has strong anti-inflammatory effect. This study aims to evaluated the level of anti-Toxoplasma immunoglobulin G and immunoglobulin M (IgG-IgM) antibody after intervention with extract in early pregnant mice with...